These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1162667)

  • 21. [Control of adverse drug reaction in a hospital environment].
    Honorato J; Giráldez J; Mart'i Mass'o R; Fos D; Velasco JL; S'anchez H
    Rev Med Univ Navarra; 1976; 20():209-11. PubMed ID: 1019512
    [No Abstract]   [Full Text] [Related]  

  • 22. Surveillance of drug adverse reactions.
    Campbell JS; Henderson IW
    Can Med Assoc J; 1972 Jun; 106(12):1285. PubMed ID: 5035130
    [No Abstract]   [Full Text] [Related]  

  • 23. [Registration, collection, and evaluation of drug side effects. Subsequent control necessary for drug security].
    Stockhausen J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):460-3. PubMed ID: 5046056
    [No Abstract]   [Full Text] [Related]  

  • 24. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society].
    Homann G
    Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792
    [No Abstract]   [Full Text] [Related]  

  • 25. The Drug Spotlight Program.
    Aagaard GN
    J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of reporting unexpected drug side effects].
    Hamvas J
    Orv Hetil; 1978 Jun; 119(24):1511. PubMed ID: 662328
    [No Abstract]   [Full Text] [Related]  

  • 27. The Swedish Adverse Drug Reaction Committee: an important tool for safer drug therapy.
    Böttiger LE
    QRB Qual Rev Bull; 1981 Feb; 7(2):14-20. PubMed ID: 6785702
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spontaneous reports on unwanted drug effects in the years 1978-1979].
    Ochsenfahrt H; Meyer zur Heyde M
    Fortschr Med; 1981 Nov; 99(42):1753-8. PubMed ID: 7308935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Not for the pharmaceutical institute: Stake on clinical pharmacology. Regional rationalization is profitable].
    Lakartidningen; 1970 Jan; 67(5):483-6. PubMed ID: 5426359
    [No Abstract]   [Full Text] [Related]  

  • 31. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse effects of drugs. Compiled and evaluated by the Committee on Drugs].
    Ochsenfahrt H
    Fortschr Med; 1984 Apr; 102(13):355-60. PubMed ID: 6724463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The national registry of drug-induced ocular side effects.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 May; 12(2):129-31. PubMed ID: 6487182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy.
    Jeffrey LP
    Hospitals; 1972 Apr; 46(7):155-60. PubMed ID: 4552323
    [No Abstract]   [Full Text] [Related]  

  • 35. [Swedish drug information of international interest].
    Osterberg S
    Lakartidningen; 1975 Jun; 72(26):2743. PubMed ID: 1142909
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of drug information].
    Lunde PK
    Tidsskr Nor Laegeforen; 1977 Jan; 97(3):150-1. PubMed ID: 835120
    [No Abstract]   [Full Text] [Related]  

  • 38. Overdosage and-or poisoning--the information gap.
    Ellenhorn MJ
    J Clin Pharmacol; 1973; 13(5):181-9. PubMed ID: 4488653
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of drugs].
    Waser PG
    Schweiz Med Wochenschr; 1966 Apr; 96(16):519-25. PubMed ID: 4861967
    [No Abstract]   [Full Text] [Related]  

  • 40. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.